Catherine Orcutt v. Andrew Saul ( 2021 )


Menu:
  •                                                                                FILED
    NOT FOR PUBLICATION
    MAR 10 2021
    UNITED STATES COURT OF APPEALS                         MOLLY C. DWYER, CLERK
    U.S. COURT OF APPEALS
    FOR THE NINTH CIRCUIT
    CATHERINE W. ORCUTT,                             No.    19-16078
    Plaintiff-Appellant,               D.C. No.
    2:15-cv-02474-JCM-PAL
    v.
    ANDREW M. SAUL, Commissioner of                  MEMORANDUM*
    Social Security,
    Defendant-Appellee.
    Appeal from the United States District Court
    for the District of Nevada
    James C. Mahan, District Judge, Presiding
    Argued and Submitted February 10, 2021
    San Francisco, California
    Before: CHRISTEN and BADE, Circuit Judges, and FEINERMAN,** District
    Judge.
    Plaintiff Catherine Orcutt appeals the district court’s order affirming the
    Commissioner of Social Security’s denial of her application for Social Security
    *
    This disposition is not appropriate for publication and is not precedent
    except as provided by Ninth Circuit Rule 36-3.
    **
    The Honorable Gary Feinerman, United States District Judge for the
    Northern District of Illinois, sitting by designation.
    disability benefits. We review de novo and may set aside a denial of benefits only
    if it is unsupported by substantial evidence or the administrative law judge (ALJ)
    committed legal error. Ford v. Saul, 
    950 F.3d 1141
    , 1154 (9th Cir. 2020). We
    have jurisdiction pursuant to 
    28 U.S.C. § 1291
     and we affirm. Because the parties
    are familiar with the facts, we recite only those necessary to resolve the arguments
    on appeal.
    1.     Orcutt argues the ALJ erred by discounting the opinion of her treating
    physician, Dr. Robinson. “Although a treating physician’s opinion is generally
    afforded the greatest weight in disability cases, it is not binding on an ALJ with
    respect to the existence of an impairment or the ultimate determination of
    disability.” Batson v. Comm’r of Soc. Sec. Admin., 
    359 F.3d 1190
    , 1195 (9th Cir.
    2004) (quoting Tonapetyan v. Halter, 
    242 F.3d 1144
    , 1149 (9th Cir. 2001)). “The
    ALJ may disregard the treating physician’s opinion whether or not that opinion is
    contradicted,” Magallanes v. Bowen, 
    881 F.2d 747
    , 751 (9th Cir. 1989), but “must
    provide ‘specific and legitimate’ reasons for rejecting the opinion of a treating
    physician,” Tommasetti v. Astrue, 
    533 F.3d 1035
    , 1041 (9th Cir. 2008) (quoting
    Lester v. Chater, 
    81 F.3d 821
    , 830–31 (9th Cir. 1995)).
    The ALJ found that Dr. Robinson’s opinion was not supported by his own
    objective findings, vague, and inconsistent with Orcutt’s daily activities. Dr.
    2
    Robinson’s examination notes from 2007 through 2012 repeatedly reflected that
    Orcutt walked well with a normal gait and presented normal station, reflex, motor,
    and sensory responses. Although Dr. Robinson consistently noted that Orcutt
    experienced pain and tenderness around the T7 vertebra, his examination findings
    are not consistent with the degree of disability Orcutt claims. See 
    id.
     Moreover,
    the objective medical evidence in the record shows that Orcutt received significant
    relief from her symptoms with interlaminar nerve block injections and the relief
    lasted for periods of up to twelve weeks. We conclude the ALJ gave specific and
    legitimate reasons for discounting Dr. Robinson’s opinion.
    2.     In the district court, Orcutt did not challenge the weight given to the
    opinions of Dr. Krutulis or Nurse Practitioner Landcastle. Assuming these
    arguments are not waived, we conclude the ALJ did not erroneously weigh these
    two opinions. As with Dr. Robinson’s opinion, the ALJ permissibly discounted the
    opinions because they were inconsistent with other evidence in the record.
    3.     Orcutt also argues the ALJ erred by discounting her subjective
    symptom testimony. An ALJ must complete a two-step analysis to determine
    whether a claimant’s symptom testimony is credible. Molina v. Astrue, 
    674 F.3d 1104
    , 1112 (9th Cir. 2012). First, the ALJ determines whether the claimant
    presented “objective medical evidence of an underlying impairment [that] could
    3
    reasonably be expected to produce the [claimant’s] pain or other symptoms
    alleged.” 
    Id.
     (internal citation omitted). Second, if the ALJ finds no evidence of
    malingering, the ALJ may reject the claimant’s symptom testimony by providing
    “specific, clear and convincing reasons” for doing so. 
    Id.
     (internal citation and
    quotation marks omitted).
    At step two, the ALJ determined Orcutt’s testimony that her limitations
    would preclude her from working was inconsistent with objective clinical findings,
    internally inconsistent, and exaggerated. As discussed, the objective medical
    evidence showed normal motor and sensory functions despite Orcutt’s reports of
    pain and tenderness around T7. The evidence also showed that the injections she
    received provided significant reduction in pain for up to twelve weeks at a time.
    Though she testified her pain precluded her from working, Orcutt testified that she
    had looked for other accounting jobs, and was working on a part-time basis at the
    time of her 2013 hearing. We conclude the ALJ provided sufficiently specific,
    clear and convincing reasons for discounting Orcutt’s testimony. See Thomas v.
    Barnhart, 
    278 F.3d 947
    , 959 (9th Cir. 2002) (“If the ALJ’s credibility finding is
    supported by substantial evidence in the record, we may not engage in second-
    guessing.”).
    4
    4.    Orcutt’s argument that the ALJ’s residual functional capacity
    determination was unsupported by substantial evidence depends on her arguments
    that the ALJ erred by discounting the opinions of Dr. Robinson, Dr. Krutulis, and
    Nurse Practitioner Landcastle. Because we conclude the ALJ did not erroneously
    weigh those medical opinions, we conclude the ALJ’s residual functional capacity
    determination was supported by substantial evidence.
    AFFIRMED.
    5